Wang Ling

1.0k total citations
32 papers, 802 citations indexed

About

Wang Ling is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wang Ling has authored 32 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Wang Ling's work include Ubiquitin and proteasome pathways (3 papers), RNA Interference and Gene Delivery (2 papers) and Maternal Mental Health During Pregnancy and Postpartum (2 papers). Wang Ling is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), RNA Interference and Gene Delivery (2 papers) and Maternal Mental Health During Pregnancy and Postpartum (2 papers). Wang Ling collaborates with scholars based in China, Japan and United States. Wang Ling's co-authors include Dianxing Sun, Haijun Li, Fubiao Kang, Dong Li, Jin‐Kun Wen, Mei Han, Bin Liu, Skjalg Bruheim, Hideo Mugishima and Peetra U. Magnusson and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Wang Ling

31 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wang Ling China 15 473 269 171 163 66 32 802
Haiyan Zhang China 15 411 0.9× 173 0.6× 210 1.2× 176 1.1× 75 1.1× 24 879
Wei‐Hung Yang Taiwan 18 397 0.8× 260 1.0× 208 1.2× 156 1.0× 38 0.6× 21 860
Yi‐Chin Fong Taiwan 22 546 1.2× 266 1.0× 251 1.5× 161 1.0× 91 1.4× 35 1.1k
Ping Guo China 13 421 0.9× 179 0.7× 181 1.1× 97 0.6× 49 0.7× 23 695
Guanqun Ge China 14 383 0.8× 195 0.7× 198 1.2× 173 1.1× 172 2.6× 28 906
Arata Nishimoto Japan 18 420 0.9× 174 0.6× 141 0.8× 74 0.5× 124 1.9× 36 802
Hema Rangaswami United States 12 713 1.5× 281 1.0× 188 1.1× 96 0.6× 67 1.0× 12 1.3k
Christina Körbel Germany 19 630 1.3× 264 1.0× 234 1.4× 154 0.9× 181 2.7× 39 1.3k
Yuqing Zhang China 15 718 1.5× 183 0.7× 340 2.0× 115 0.7× 68 1.0× 22 1.0k
Shyun-Yeu Liu Taiwan 17 339 0.7× 254 0.9× 170 1.0× 169 1.0× 66 1.0× 24 755

Countries citing papers authored by Wang Ling

Since Specialization
Citations

This map shows the geographic impact of Wang Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang Ling more than expected).

Fields of papers citing papers by Wang Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wang Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang Ling. The network helps show where Wang Ling may publish in the future.

Co-authorship network of co-authors of Wang Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Wang Ling. A scholar is included among the top collaborators of Wang Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wang Ling. Wang Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Song, Jingsong Shi, Xiaodong Xu, et al.. (2023). TYRO3 protects podocyte via JNK/c-jun-P53 pathway. Archives of Biochemistry and Biophysics. 739. 109578–109578. 4 indexed citations
2.
Zhang, Haiquan, Wang Ling, Shu‐Liang Li, et al.. (2023). Super-hydrophobic wood composite with plexiglass coating. Engineered Science. 20 indexed citations
3.
Chen, Peier, Xiaodong Ning, Wang Ling, et al.. (2022). Fabrication of Tβ4-Exosome-releasing artificial stem cells for myocardial infarction therapy by improving coronary collateralization. Bioactive Materials. 14. 416–429. 30 indexed citations
4.
Ling, Wang, et al.. (2021). Overexpression of Epithelial Splicing Regulatory Protein 1 in Metastatic Lesions of Serous Ovarian Carcinoma Correlates with Poor Patient Prognosis. Cancer Biotherapy and Radiopharmaceuticals. 37(9). 850–861. 4 indexed citations
5.
Li, Miao, Meng Pan, Jing Wang, et al.. (2020). miR-7 Reduces Breast Cancer Stem Cell Metastasis via Inhibiting RELA to Decrease ESAM Expression. Molecular Therapy — Oncolytics. 18. 70–82. 28 indexed citations
6.
Zhang, Chunhua, et al.. (2019). The effects of TCM nursing intervention on the life quality of cancer patients with pain: a review of recent research. SHILAP Revista de lepidopterología. 1 indexed citations
7.
Ling, Wang, et al.. (2015). Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma. Tumor Biology. 37(3). 2961–2971. 45 indexed citations
8.
Liu, Xinyu, Xianglu Li, Wang Ling, et al.. (2013). Realgar induces apoptosis in the chronic lymphocytic leukemia cell line MEC-1. Molecular Medicine Reports. 8(6). 1866–1870. 3 indexed citations
9.
Wang, Hui, Yongping Li, Jianghao Chen, et al.. (2013). Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma. Tumor Biology. 34(3). 1635–1639. 39 indexed citations
10.
Cheng, Zhiqiang, Jun Shan, Likun Gao, et al.. (2010). Detection of p53 gene deletion in primary lung cancer by Dual-FISH technique and it's clinical significance. 26(4). 368–371. 1 indexed citations
11.
Liu, Hui, et al.. (2009). Responses of mRNA expression of PepT1 in small intestine to graded duodenal soybean small peptides infusion in lactating goats.. AFRICAN JOURNAL OF BIOTECHNOLOGY. 8(9). 1973–1978. 5 indexed citations
12.
Zhao, Lianmei, Jun Ai, Qian Zhang, et al.. (2009). Periplocin (a sort of ethanol from Cortex periplocae) induces apoptosis of esophageal carcinoma cells by influencing expression of related genes.. Tumori. 29(11). 1025–1030. 2 indexed citations
13.
Liu, Lihua, Baoen Shan, Shijie Wang, Jun Meng, & Wang Ling. (2009). Serum proteomic spectra of esophageal carcinoma patients and a corresponding esophagial carcinoma diagnostic model.. 16(3). 272–276. 1 indexed citations
14.
Ranuncolo, Stella Maris, Wang Ling, José M. Polo, et al.. (2008). BCL6-mediated Attenuation of DNA Damage Sensing Triggers Growth Arrest and Senescence through a p53-dependent Pathway in a Cell Context-dependent Manner. Journal of Biological Chemistry. 283(33). 22565–22572. 35 indexed citations
15.
Ling, Wang. (2007). Determination of lymphatic vessel density in breast cancer patients receiving neoadjuvant chemotherapy. Zhongguo aizheng zazhi. 2 indexed citations
16.
Liu, Bin, Mei Han, Jin‐Kun Wen, & Wang Ling. (2007). Livin/ML-IAP as a new target for cancer treatment. Cancer Letters. 250(2). 168–176. 65 indexed citations
17.
Matsumoto, Tarô, Svante Bohman, Johan Dixelius, et al.. (2005). VEGF receptor‐2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. The EMBO Journal. 24(13). 2342–2353. 220 indexed citations
18.
Ling, Wang, Katsuhiro Higashiura, Nobuyuki Ura, Tetsuji Miura, & Kazuaki Shimamoto. (2003). Chinese Medicine, Jiang-Tang-Ke-Li, Improves Insulin Resistance by Modulating Muscle Fiber Composition and Muscle Tumor Necrosis Factor-.ALPHA. in Fructose-Fed Rats. Hypertension Research. 26(7). 527–532. 15 indexed citations
19.
Ling, Wang, Katsuhiro Higashiura, Nobuhiko Togashi, et al.. (2001). Effects of the Chinese Medicine Jiang-Tang-Ke-Li on Insulin Resistance in Fructose-Fed Rats.. Hypertension Research. 24(3). 303–309. 6 indexed citations
20.
Li, Yi, Katsuhiro Higashiura, Nobuyuki Ura, et al.. (2000). Effects of the Chinese Medicine TSJN on Insulin Resistance and Hypertension in Fructose-Fed Rats.. Hypertension Research. 23(2). 101–107. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026